Viewing Study NCT03844061


Ignite Creation Date: 2025-12-24 @ 11:53 AM
Ignite Modification Date: 2026-01-03 @ 5:08 PM
Study NCT ID: NCT03844061
Status: RECRUITING
Last Update Posted: 2025-03-13
First Post: 2019-01-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
Sponsor: Hospital for Special Surgery, New York
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module